# Health Canada

Type: organization

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/health-canada
Canonical HTML page: https://getbiobrief.com/entity/health-canada

## Timeline

- **2026-03-22**: Public Health Advisory — Health authorities issue guidance for parents on how to identify and return the product.
- **2026-03-21**: Retailer Notification — Pharmacies and retailers begin the process of removing affected lots from shelves.
- **2026-03-20**: Recall Announcement — Initial reports confirm nearly 90,000 bottles are affected by a safety recall.
- **2026-02-26**: Cure Announcement — Medical officials formally announce the patient is cured, marking a global first for gene editing technology.
- **2025-07-20**: Six-Month Follow-up — Clinical evaluations confirm significant biological markers of recovery and the absence of off-target effects.
- **2025-01-10**: Therapy Administration — A one-time gene editing intervention is administered at a specialized pediatric facility in British Columbia.
- **2024-06-15**: Trial Enrollment — The B.C. teen is enrolled in a world-first experimental gene editing clinical trial for a rare genetic disorder.
- **2024**: Phase 3 Trials — Large-scale multi-site trials aim to provide definitive data for regulatory approval.
- **2022**: SAP Expansion — Canada amends the Special Access Program to include restricted psychedelic substances.
- **2020**: Regulatory Shift — Health Canada begins granting Section 56 exemptions for terminally ill patients.
- **2016**: Foundational Research — Johns Hopkins and NYU publish landmark studies on psilocybin for cancer-related distress.

## Recent coverage (3 stories)

### Nearly 90,000 Bottles of Children’s Liquid Pain Medication Recalled
2026-03-20 19:55:42 · Sentiment: Negative · Impact: 6/10 · Sources: 3

A major recall involving nearly 90,000 bottles of children’s liquid pain medication has been launched across North America. The recall highlights critical safety concerns regarding pediatric dosage accuracy and quality control in the over-the-counter pharmaceutical sector.
Full story: https://getbiobrief.com/story/pediatric-pain-medication-recall-90000-bottles

### Psilocybin Shows Clinical Promise in Easing End-of-Life Existential Distress
2026-03-06 15:49:59 · Sentiment: Positive · Impact: 7/10 · Sources: 2

Emerging clinical research indicates that psilocybin-assisted therapy can significantly alleviate existential dread and depression in terminally ill patients. This development marks a potential paradigm shift in palliative care, moving beyond physical pain management to address deep-seated psychological trauma.
Full story: https://getbiobrief.com/story/psilocybin-end-of-life-clinical-promise

### B.C. Teen Becomes First in World Cured of Rare Disease via Gene Editing
2026-02-26 02:26:16 · Sentiment: Strongly positive · Impact: 8/10 · Sources: 2

A British Columbia teenager has achieved a historic medical milestone, becoming the first person globally to be cured of a rare genetic disease using advanced gene editing technology. This breakthrough marks a definitive shift in the treatment of rare disorders, moving from chronic management to a potential one-time curative intervention.
Full story: https://getbiobrief.com/story/bc-teen-first-world-gene-editing-cure

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.